Evaluation of Neovis® Total Multi Versus Systane® Balance on Ocular Dryness Associated With Meibomian Gland Dysfunction
Clinical trial NCT05191771 · UNKNOWN
Trial details
- NCT number
- NCT05191771
- Sponsor
- Horus Pharma
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-01
- Primary completion
- 2022-10-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.